A Venture capital view of challenges, opportunities, and innovation in biomedical research

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 2, 2011, Pages 174-176

  Ratcliffe, L T ^a  

^a New Leaf Venture Partners   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; ILOPERIDONE; ROTIGOTINE; SORAFENIB; TELAVANCIN;

DRUG INDUSTRY; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW;

BIOMEDICAL RESEARCH; BIOTECHNOLOGY; CAPITAL FINANCING; CREATIVENESS; DRUG INDUSTRY;

EID: 78951476697     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.284     Document Type: Review

References (2)

1. Morrison, C. & Licking, E.F. Biotech backers are learning to live with exit-by-earn out. Start-Up, March 2010: 16-20.
2. Lash, A. In the midst of a shakeout, Biotech VCs must embrace new partners, New math. Start- Up, September 2010: 24-30.